Episode 52 - Drug Survivability of Omalizumab in Chronic Urticaria

from All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier · host UCARE, the Global Allergy and Asthma Excellence Network for Urticaria

Dr Heike Röckmann, head of the drug survivability of omalizumab in chronic urticaria (DruSO-CU) project joins Professor Marcus Maurer to discuss the global project, the difficulties which were encountered, and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.

Episode metadata supplied by the publisher feed · Published Dec 12, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 52 - Drug Survivability of Omalizumab in Chronic Urticaria

0:00 21:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier?

This episode is 21 minutes long.

When was this All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier episode published?

This episode was published on December 12, 2022.

Can I download this All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!